ANRS Infectious emerging diseases (MIE), autonomous agency of Inserm, facilitates, evaluates, coordinates and funds research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging and re-emerging infectious diseases.
A central role in infectious diseases research for over 35 years
Supporting research to prevent, understand and treat infectious diseases
ANRS MIE three majors levels of action
ANRS MIE is an agency operating under the specific status of an autonomous agency within Inserm.
Patient associations, next generation of scientists, quality and ethical approach, open science
Exceptional procedure for responding to emerging or re-emerging epidemics
Our agency funds, coordinates, evaluates and facilitates research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging infectious diseases.
Learn more about the diseases and pathogens covered by our research
Information on the projects we fund
Our workgroups bring together researchers and representatives of civil society
Guiding and advising innovative project leaders
The agency supports a number of research platforms and networks to federate and help shape research in its field
National and international research platforms supported by the agency and designed for the scientific community
Clinical research networks and networks of young researchers
Access to data and biological collections from research promoted by the agency
The agency is a member of various networks and forges partnerships with national and international associations, organisations and initiatives
Partner sites, international global health research platforms, ad hoc partnerships
WHO, Ministry of Europe and Foreign Affairs, Global Health EDCTP3 Joint Undertaking, structuring networks
Strategic international projects and capacity-building programmes
Fighting epidemics: ANRS MIE leads WHO filovirus CORC
Collaboration with community stakeholders
Each year, the agency offers two calls for generic projects and calls for thematic projects. Some are jointly carried out with other research players
Agency's current, forthcoming and completed calls for proposals
Find out the list of calls for projects previously funded by the agency
Find out the Start programme, here to support and guide the next generation of scientific researchers
Submit a project
Here you can find all the latest news and events relating to our areas of research.
Share:
Trier par
In a study published in Nature, researchers from the Institut Pasteur, Université Paris Cité and the Vaccine Research Institute (VRI) have identified the entry point of a seasonal coronavirus, the HKU1 virus, into human cells.
Would you like to find out more about European calls for projects, but you do not know if they are right for your activities, or where to start? Three informative webinars are open to you in the coming weeks, to help you understand which instrument is suitable for your objectives and activities, who...
This new strategy is the roadmap for all French parties involved to meet the challenges of global health: achieving the Sustainable Development Goals (SDGs), in particular SDG 3 for the health and well-being of people at all ages. The aim is to defend universal access to health, prevent and combat...
France 2030: 11 winning projects for the 2023 PEPR MIE call for projects, funded to better understand and prepare to respond to emerging infectious diseases for nearly 22 million euros.
ANRS | Emerging Infectious Diseases will commission an independent audit
A study by researchers from the French Alternative Energies and Atomic Energy Commission (CEA), Inserm and University Paris Cité, who are part of the Preclinical Studies Group (GEPC)* set up by ANRS | Emerging Infectious Diseases, evaluated the effects of favipiravir on SARS-CoV-2 and the Zika...
